All News #Library
Generics
Zydus, Synthon Ink Exclusive Licensing Deal for Ozanimod Capsules
04 Sep 2025 //
PR NEWSWIRE
Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical
24 Nov 2018 //
PATENT LITIGATION
Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon
21 Jun 2018 //
PATENT LITIGATION
Synthon`s generic version of Copaxone 40mg approved in Europe
06 Oct 2017 //
IN PHARMATECHNOLOGIST
Updated: Copaxone Generics: Who Will Win First Filer Exclusivity?
04 Oct 2017 //
RAPS
Copaxone (Glatiramer acetate): Teva v. Synthon Pharmaceuticals & Pfizer
07 Apr 2017 //
PATENT LITIGATION
Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay
22 Feb 2017 //
IN PHARMATECHNOLOGIST
Pfizer Grabs Commercialization Rights of Potential MS Generic Treatment Glatiramer Acetate
03 Aug 2015 //
BIOSPACE

Market Place
Sourcing Support